References

  1. Gattegno B, Haab F. fibrose rétropéritonéale. Encycl Med Chir6 (Editions Scientifiques et Medicale Elsevier SAS, Paris) Néphrologie-Urologue. 1992; 18-162-A-10. Google Scholar

  2. Hartman D. Retroperitoneal fibrosis. AJR.1994; 162(6): 1454-6. PubMed | Google Scholar

  3. Gary S, Gilkeson MD, Nancy B, Allen MD. Retroperitoneal fibrosis: a true connective disease. Rheumatic Disease Clinics of North America. 1996; 22(1): 23-38. Google Scholar

  4. Demko TM, Diamond JR, Groff J. Obstructive nephropathy as a result of retroperitoneal fibrosis: a review of its pathogenesis and associations. J Am Society of Nephrology. 1997; 8(4): 684-8. PubMed | Google Scholar

  5. Witten DM, In: Pollack HM, editor. Retroperitoneal fibrosis: clinical urography. Philadelphia: WB Saunders Co. 1990; p 2470-6. Google Scholar

  6. Arrive L, Hricak H, Tavares NJ, Miller TR. Malignant versus non-malignant retroperitoneal fibrosis: differenciation with MR imaging. Radiology. 1989; 172(1): 139-43. Google Scholar

  7. Brooks AP, Reznek RH, Webb JAW. Magnetic resonance imaging of idiopathic retroperitoneal fibrosis: measurement of T1 relaxation time. Br J Radiol. 1990; 63(755): 842. PubMed | Google Scholar

  8. Benson JR, Baum M. Tamoxifen for retroperitoneal fibrosis. Lancet. 1993; 341(8848): 836. PubMed | Google Scholar

  9. Clark CP, Vanderpool D, Preskitt JT. The response of idiopathic retroperitoneal fibrosis to tamoxifen. Surgery. 1991; 109(4): 109-502. Google Scholar

  10. Speziale F, Sbarigia E, Grossi R. Inflammatory aneurysms of the abdominal aorta involving the ureters: is combined treatment really necessary? J Urol. 2001; 165(1): 27-31. PubMed | Google Scholar